Inogen, Inc. (FRA:6IO)

Market Cap	133.42M -50.8%
Revenue (ttm)	295.77M +4.7%
Net Income	-21.63M
EPS	-0.84
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	4
Open	4.900
Previous Close	4.880
Day's Range	4.900 - 4.900
52-Week Range	4.640 - 10.100
Beta	n/a
RSI	45.81
Earnings Date	Feb 24, 2026

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related a...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2001
• Employees: 766
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6IO

Financial Performance

In 2024, Inogen's revenue was $335.71 million, an increase of 6.35% compared to the previous year's $315.66 million. Losses were -$35.89 million, -64.97% less than in 2023.

Financial numbers in USD